￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Lorlatinib/Lorlatinib (Lorlatinib) comes in several versions

2026-02-01 22:25:32

Check Details
The difference between lorlatinib and lorlatinib

2026-02-01 22:25:32

Check Details
ABBV-599, a novel combination of upadacitinib, improves lupus, expands pathology coverage

2026-02-01 22:25:32

Check Details
A study comparing the efficacy of upadacitinib and ustekinumab in the treatment of ulcerative colitis

2026-02-01 22:25:32

Check Details
New Phase 3 Data Shows Long-Term Efficacy of Upadacitinib in Atopic Dermatitis

2026-02-01 22:25:32

Check Details
Final U-ACHIEVE analysis: Upadacitinib is well tolerated and maintains clinical remission in ulcerative colitis

2026-02-01 22:25:32

Check Details
AbbVie's Upadacitinib shows long-term, sustained efficacy in atopic dermatitis

2026-02-01 22:25:32

Check Details
What diseases does Upadacitinib treat?

2026-02-01 22:25:32

Check Details
Upadacitinib launch date in China

2026-02-01 22:25:32

Check Details
How much does Upadacitinib cost?

2026-02-01 22:25:32

Check Details
Where to buy Upadacitinib

2026-02-01 22:25:32

Check Details
When will Upadacitinib be included in medical insurance?

2026-02-01 22:25:32

Check Details
Category
相关知识